Scientists from Stanford Medicine have discovered a gene variant, DR4 allele, that provides protection against both Alzheimer’s and Parkinson’s disease. Analyzing data from various continents, researchers found that this gene…
Researchers developed a groundbreaking blood test, Mito DNADX, for early Parkinson's detection by identifying mitochondrial DNA damage, potentially transforming current diagnostic methods based on late-stage symptoms.
In a groundbreaking study, Bayer's subsidiary, BlueRock Therapeutics, revealed positive early-stage results for its stem cell therapy aimed at treating Parkinson's disease. The trial, consisting of 12 participants, demonstrated that the therapy was both safe and well-tolerated.
Groundbreaking a new study reveals that smartwatches can detect Parkinson's disease seven years before symptoms arise, offering a glimmer of hope in its early diagnosis and treatment.
Parkinson’s disease is a slow progressing neurological disorder that is generally seen between 55 and 65 years of age and causes damage to brain cells.